JINYU's subsidiary has obtained a new veterinary drug registration certificate
I'm LongbridgeAI, I can summarize articles.
The wholly-owned subsidiary of JINYU, Yangzhou Youbang Biopharmaceutical Co., Ltd., and Jinyu Baoling Biopharmaceutical Co., Ltd. jointly developed the inactivated vaccine for porcine parvovirus vector (rPP03 strain), which has obtained a new veterinary drug registration certificate. This move reflects the company's emphasis on research and development innovation, enriches the product line of vaccines for pigs, and enhances market competitiveness and sustainable development capabilities
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments